Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Biocept Inc
(NQ:
BIOC
)
5.360
USD
-0.120 (-2.19%)
Official Closing Price
Updated: 7:57 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
461,300
Open
5.540
Bid (Size)
5.310 (100)
Ask (Size)
5.330 (12)
Prev. Close
5.480
Today's Range
5.300 - 5.740
52wk Range
0.2100 - 6.350
Shares Outstanding
68,213,349
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Biocept to Present at H.C. Wainwright Virtual BioConnect Conference
January 04, 2021
CEO Michael Nall to participate in diagnostics and devices panel discussion hosted by former FDA Commissioner Dr. Scott Gottlieb
From
PR Newswire
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 31, 2020
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve...
From
PR Newswire
Performance
YTD
+13.08%
+13.08%
1 Month
+8.94%
+8.94%
3 Month
+14.53%
+14.53%
6 Month
+661.47%
+661.47%
1 Year
+1414.12%
+1414.12%
More News
Read More
Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations
December 30, 2020
From
PR Newswire
Biocept Provides Business Update
December 14, 2020
From
PR Newswire
Biocept Issues Letter to Stockholders
January 12, 2021
From
Business Wire News Releases
Biocept's Target Selector™ Liquid Biopsy Demonstrated High Accuracy When Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins Sidney Kimmel Cancer Center
December 10, 2020
From
PR Newswire
While The U.S. Faces Insufficient COVID-19 Testing Volume, EIR Healthcare Launches MedModLabs to Expand Access Immediately
December 01, 2020
From
PR Newswire
Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central N
November 20, 2020
From
PR Newswire
Results from Study Using Biocept's Target Selector™ Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS®
November 17, 2020
From
PR Newswire
Biocept Reports Third Quarter 2020 Financial Results
November 12, 2020
From
PR Newswire
12 Healthcare Stocks Moving In Friday's Intraday Session
November 13, 2020
Tags
NMTR
ARPO
SAVA
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.